Universität Hamburg-Eppendorf
Welcome,         Profile    Billing    Logout  
 6 Trials 
7 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Kluge, Stefan
PEPPER, NCT03334006 / 2016-001788-34: Prospective, Randomized Trial of Personalized Medicine with Pentaglobin® After Surgical Infectious Source Control in Patients with Peritonitis

Recruiting
2
200
Europe
Pentaglobin®/Standard of Care
RWTH Aachen University, Biotest
Peritonitis, Sepsis, Septic Shock
09/27
03/28
FORTRESS, NCT02979951: Fosfomycin I.v. for Treatment of Severely Infected Patients

Recruiting
N/A
1000
Europe
Infectopharm Arzneimittel GmbH, INPADS GmbH, Dr. Oestreich + Partner GmbH
Bacterial Infections, Bone Diseases, Infectious, Osteomyelitis, Central Nervous System Bacterial Infections, Meningitis, Bacterial, Encephalitis, Brain Abscess, Urinary Tract Infections, Respiratory Tract Infections, Pneumonia, Bacterial, Skin Diseases, Bacterial, Soft Tissue Infections, Intraabdominal Infections, Sepsis, Bacteremia, Endocarditis, Bacterial
12/30
12/30
ACYSS, NCT04013269: Adjuvant Therapy With CytoSorb in Refractory Septic Shock

Recruiting
N/A
32
Europe
CytoSorb-Therapy
Universitätsklinikum Hamburg-Eppendorf, CytoSorbents, Inc
Septic Shock
12/23
12/23
multiECCO2R, NCT04871893: Safety and Efficacy Evaluation of CO2 Removal in Combination with Continuous Veno-Venous Hemodialysis/Hemodiafiltration Therapy

Recruiting
N/A
40
Europe
multiECCO2R blood-gas exchanger
Fresenius Medical Care Deutschland GmbH, CERES GmbH
Acute Lung Injury, Acute Kidney Injury, Hypercapnia, Covid19
12/24
03/25
PROCYSS, NCT04963920: A RCT to Assess the Performance of CytoSorb for Shock Reversal in Patients With Vasoplegic Septic Shock

Recruiting
N/A
260
Europe
Cytosorb® 300 ml
CytoSorbents Europe GmbH, BRAHMS GmbH, MedInnovation GmbH
Septic Shock
02/25
05/25
PhINEST, NCT03840395: The Study - Pharyngeal ICU Novel Electrical Stimulation Therapy

Recruiting
N/A
360
Europe
Pharyngeal Electrical Stimulation (PES), Phagenyx
Phagenesis Ltd., NAMSA, Cytel Inc.
Dysphagia
09/25
12/25
Schädler, Dirk
FORTRESS, NCT02979951: Fosfomycin I.v. for Treatment of Severely Infected Patients

Recruiting
N/A
1000
Europe
Infectopharm Arzneimittel GmbH, INPADS GmbH, Dr. Oestreich + Partner GmbH
Bacterial Infections, Bone Diseases, Infectious, Osteomyelitis, Central Nervous System Bacterial Infections, Meningitis, Bacterial, Encephalitis, Brain Abscess, Urinary Tract Infections, Respiratory Tract Infections, Pneumonia, Bacterial, Skin Diseases, Bacterial, Soft Tissue Infections, Intraabdominal Infections, Sepsis, Bacteremia, Endocarditis, Bacterial
12/30
12/30

Download Options